跳轉至內容
Merck
全部照片(3)

重要文件

466387

Sigma-Aldrich

Brij® S 100

average Mn ~4,670

同義詞:

聚氧乙烯(100)十八烷基醚

登入查看組織和合約定價


About This Item

線性公式:
C18H37(OCH2CH2)nOH, n~100
CAS號碼:
MDL號碼:
分類程式碼代碼:
12162002
PubChem物質ID:
NACRES:
NA.23

分子量

average Mn ~4,670

mp

51-54 °C (lit.)

羥值

13‑25 mg KOH/g

溶解度

propylene glycol and xylene: insoluble

密度

1.1 g/mL at 25 °C (lit.)

HLB

18

SMILES 字串

O(CC[O])CCCCCCCCCCCCCCCCCC

InChI

1S/C20H41O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-22-20-18-21/h2-20H2,1H3

InChI 密鑰

PSEGVHKUPXNGGJ-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

應用

Brij® S 100 可用于:
  • 作为一种非离子表面活性剂研究其与鲁米诺的相互作用电化学发光用于生物分析
  • 作为载体材料,利用气体饱和溶液(PGSS)工艺中的颗粒研究尼莫地平、非诺贝特和 香草醛的配方
  • 作为浇铸溶液中的亲水性表面活性剂,制备不对称平板纳滤膜,并研究其对聚醚砜(PES)纳滤膜亲水性能的影响

法律資訊

Brij is a registered trademark of Croda International PLC

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

Slide 1 of 2

1 of 2

S Rahima Benhabbour et al.
Journal of controlled release : official journal of the Controlled Release Society, 158(1), 63-71 (2011-11-01)
Lipid-based oil-filled nanoparticles (NPs) with a high concentration of surface-chelated nickel (Ni-NPs) were successfully prepared using a Brij 78-NTA-Ni conjugate synthesized with Brij 78 (Polyoxyethylene (20) stearyl ether) and nitrilotriacetic acid (NTA). The facile incorporation of the Brij 78-NTA-Ni conjugate
L Realini et al.
Journal of clinical microbiology, 35(11), 2791-2794 (1997-11-14)
We report on the influences of polyoxyethylene stearate (POES), PANTA, and pH on primary cultures of Mycobacterium genavense in BACTEC vials. As a model for primary cultures from tissue, seven different strains first isolated from AIDS patients (five from Switzerland
S X Liu et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 11(3), 279-282 (1995-01-01)
Although sufficient amount of glucagon can be taken up into systemic circulation through ocular route, the concentration of eyedrops needed at 7.5% would be too high and the price of the doses would be too expensive to be desirable. Attempts
Jigna D Patel et al.
Pharmaceutical research, 24(2), 343-352 (2006-12-21)
The purpose of these studies was to prepare nanoparticles (NPs) with a small amount of surface-chelated nickel for obtaining enhanced binding of histidine-tagged (his-tag) proteins compared to non-histidine-tagged protein binding to charged nanoparticles. NPs were prepared from oil-in-water microemulsion precursors
Tatsuaki Tagami et al.
Journal of controlled release : official journal of the Controlled Release Society, 152(2), 303-309 (2011-02-23)
We have developed a novel and simplified thermosensitive liposomal formulation (HaT: Hyperthermia-activated cytoToxic) composed of DPPC lipid and Brij78 (96:4, molar ratio). The HaT nanoparticles were loaded with doxorubicin (DOX) with >95% efficiency when a pH gradient method and a

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務